Matthew W. Foehr, Director at Viking Therapeutics, Inc. (VKTX), bought 90,000 shares at $2.47 ($222K) on 2022-05-02, disclosed to the SEC on 2022-05-03.
Open-market purchase of $222k VKTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.47 | 45,000 | $111K | 50.0% |
| 2 | $2.47 | 45,000 | $111K | 50.0% |
| Total | $2.47 avg | 90,000 | $222K | 100% |
| Filing → |
| OABI | SELL | 2026-02-17 | $35K | — | Filing → |
| VKTX | SELL | 2026-01-05 | $1.1M | — | Filing → |
| OABI | SELL | 2025-12-09 | $27K | — | Filing → |